Klaus Wunderling

Klaus Wunderling

Auto-generated profile, based on publicly available information

Klaus Wunderling

Biochemistry and Cell Biology of Lipids, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
KWKlaus Wunderling
Klaus Wunderling
JZJelena Zurkovic
Jelena Zurkovic
FZFabian Zink
Fabian Zink
LKLars Kuerschner
Lars Kuerschner
CTChristoph Thiele
Christoph Thiele
Triglyceride cycling is the process of continuous degradation and re-synthesis of triglyceride in cellular stores. We show in 3T3-L1 adipocytes that triglycerides are subject to rapid turnover and re-arrangement of fatty acids with an estimated half-life of 2–4 h. We develop a tracing technology that can simultaneously and quantitatively follow the metabolism of multiple fatty acids to study the triglyceride futile substrate cycle directly and with molecular species resolution. Our approach is based on alkyne fatty acid tracers and mass spectrometry. The triglyceride cycling is connected to modification of released fatty acids by elongation and desaturation. Through cycling and modification, saturated fatty acids are slowly converted to monounsaturated fatty acids, and linoleic acid to arachidonic acid. We conclude that triglyceride cycling renders stored fatty acids accessible for metabolic alteration. The overall process facilitates cellular adjustments to the stored fatty acid pool to meet changing needs of the cell.

14 October 2019 in Nature Methods
Verified
Journal Article
Closed access
PDF file
CTChristoph Thiele
Christoph Thiele
KWKlaus Wunderling
Klaus Wunderling
PLPhilipp Leyendecker
Philipp Leyendecker

18 June 2025 in Nature
Verified
Journal Article
Open access
PDF file
HHHao Huang
Hao Huang
NBNora R. Balzer
Nora R. Balzer
LSLea Seep
Lea Seep
ISIva Splichalova
Iva Splichalova
NBNelli Blank-Stein
Nelli Blank-Stein
EMElvira Mass
Elvira Mass
Kupffer cells (KCs) are tissue-resident macrophages that colonize the liver early during embryogenesis1. Upon liver colonization, KCs rapidly acquire a tissue-specific transcriptional signature, mature alongside the developing liver and adapt to its functions1,2,3. Throughout development and adulthood, KCs perform distinct core functions that are essential for liver and organismal homeostasis, including supporting fetal erythropoiesis, postnatal erythrocyte recycling and liver metabolism4. However, whether perturbations of macrophage core functions during development contribute to or cause disease at postnatal stages is poorly understood. Here, we utilize a mouse model of maternal obesity to perturb KC functions during gestation. We show that offspring exposed to maternal obesity develop fatty liver disease, driven by aberrant developmental programming of KCs that persists into adulthood. Programmed KCs promote lipid uptake by hepatocytes through apolipoprotein secretion. KC depletion in neonate mice born to obese mothers, followed by replenishment with naive monocytes, rescues fatty liver disease. Furthermore, genetic ablation of the gene encoding hypoxia-inducible factor-α (HIF1α) in macrophages during gestation prevents the metabolic programming of KCs from oxidative phosphorylation to glycolysis, thereby averting the development of fatty liver disease. These results establish developmental perturbation of KC functions as a causal factor in fatty liver disease in adulthood and position fetal-derived macrophages as critical intergenerational messengers within the concept of developmental origins of health and diseases5.

1 March 2021 in Molecular Metabolism
Verified
Journal Article
Open access
KWKlaus Wunderling
Klaus Wunderling
CLChristina Leopold
Christina Leopold
IJIsabell Jamitzky
Isabell Jamitzky
MYMohamed Yaghmour
Mohamed Yaghmour
FZFabian Zink
Fabian Zink
CTChristoph Thiele
Christoph Thiele
Medium-chain fatty acids (MCFAs) play an increasing role in human nutrition. In the liver, one fraction is used for synthesis of MCFA-containing triacylglycerol (MCFA-TG), and the rest is used for oxidative energy production or ketogenesis. We investigated which enzymes catalyse the synthesis of MCFA-TG and how inhibition of MCFA-TG synthesis or fatty acid (FA) oxidation influences the metabolic fate of the MCFAs. FA metabolism was followed by time-resolved tracing of alkyne-labelled FAs in freshly isolated mouse hepatocytes. Quantitative data were obtained by mass spectrometry of several hundred labelled lipid species. Wild-type hepatocytes and cells from diacylglycerol acyltransferase (DGAT)1-/- mice were treated with inhibitors against DGAT1, DGAT2, or FA β-oxidation. Inhibition or deletion of DGAT1 resulted in a reduction of MCFA-TG synthesis by 70%, while long-chain (LC)FA-TG synthesis was reduced by 20%. In contrast, DGAT2 inhibition increased MCFA-TG formation by 50%, while LCFA-TG synthesis was reduced by 5-25%. Inhibition of β-oxidation by the specific inhibitor teglicar strongly increased MCFA-TG synthesis. In contrast, the widely used β-oxidation inhibitor etomoxir blocked MCFA-TG synthesis, phenocopying DGAT1 inhibition. DGAT1 is the major enzyme for hepatic MCFA-TG synthesis. Its loss can only partially be compensated by DGAT2. Specific inhibition of β-oxidation leads to a compensatory increase in MCFA-TG synthesis, whereas etomoxir blocks both β-oxidation and MCFA-TG synthesis, indicating a strong off-target effect on DGAT1.

11 August 2023 in Research Square
Verified
Preprint
Open access
PDF file
HHHao Huang
Hao Huang
ISIva Splichalova
Iva Splichalova
NBNora Balzer
Nora Balzer
LSLea Seep
Lea Seep
ETEliana Franco Taveras
Eliana Franco Taveras
EMElvira Mass
Elvira Mass
Kupffer cells (KCs) are tissue-resident macrophages which colonize the developing liver early during embryogenesis1. Throughout development and adulthood, KCs have distinct core functions that are essential for liver and organismal homeostasis, such as supporting fetal erythropoiesis as well as postnatal erythrocyte recycling and liver metabolism2. KCs start to acquire their tissue-specific transcriptional signature immediately after colonizing the liver, mature together with the tissue, and adapt to the tissue’s function1,3,4. However, whether perturbations of macrophage core functions during development contribute to or cause disease at postnatal stages is poorly understood. Here, we utilize a maternal obesity model to perturb KC functions during gestation. We show that mice experiencing maternal obesity during gestation develop fatty liver disease that is accompanied by a local inflammatory response. Transcriptional analyses reveal that KCs undergo developmental programming through maternal obesity, which persists in adulthood. The offspring’s KC developmental programming is irreversible and leads to increased lipid uptake in hepatocytes mediated via KCs. The transcriptional programming of KCs and the fatty liver disease phenotype are rescued by genetic depletion of hypoxia-inducible factor alpha (Hif1α) in macrophages during gestation. These results establish developmental perturbation of KC functions as a cause for the development of fatty liver disease in adult life and, thereby, place fetal-derived macrophages as intergenerational messengers within the concept of developmental origins of health and diseases5.

25 March 2026 in iScience
Verified
Journal Article
Open access
PJPaul Jonas Jost
Paul Jonas Jost
DWDaniel Weindl
Daniel Weindl
KWKlaus Wunderling
Klaus Wunderling
CTChristoph Thiele
Christoph Thiele
JHJan Hasenauer
Jan Hasenauer
Cellular heterogeneity is a fundamental facet of cell biology, influencing cellular signaling, metabolism, and gene regulation. Its accurate quantification requires measurements at the single-cell level. Most high-throughput single-cell technologies provide only a snapshot of cellular heterogeneity at a specific time point because the measurement is destructive. This limits our current ability to understand the dynamics of cellular behavior and quantify cell-specific parameters. We propose a potential experimental setup combined with a model-based analysis framework, enabling the extraction of longitudinal data from a single destructive measurement. Although broadly applicable, we focus on lipid metabolism, a domain where obtaining longitudinal single-cell data have remained elusive due to technical constraints. Our method leverages multiple labels whose measurements are linked to a shared dynamic. This allows the estimation of cell-specific parameters and the quantification of heterogeneity. This framework establishes a foundation for future investigations, providing a roadmap toward a deeper understanding of dynamic cellular processes.